Neural Correlates (EEG and fMRI) of Gait in Small Vessel Disease

What is the purpose of this study? This observational study is being done to understand how cerebral small vessel disease (SVD) affects walking and balance. SVD is a common brain condition in older adults that damages small blood vessels. It can lead to problems with movement, thinking, and memory. The researchers want to find out how changes in brain activity and connectivity contribute to walking difficulties in people with SVD. Why is this study important? Walking and balance problems increase the risk of falls and loss of independence. By studying brain activity during walking-related tasks, researchers hope to identify patterns that explain why these problems happen. This knowledge could help develop better rehabilitation methods in the future. Who can participate? Adults over 50 years old with cerebral small vessel disease and gradual gait problems may be eligible. Healthy adults of similar age without neurological problems may also take part as control participants. What will happen in this study? Participants will: Complete walking, balance, and cognitive tests such as the Timed Up and Go, Berg Balance Scale, and Montreal Cognitive Assessment. Undergo brain imaging (MRI) to confirm the diagnosis and study brain structure and function. Have an EEG recording while resting and while watching short videos showing walking and turning movements. A smaller group will also undergo functional MRI (fMRI) while watching the same videos. The MRI and EEG results will be analyzed to see how brain networks involved in movement and balance differ between patients and healthy adults. How long will the study take? The study will take about two years to complete. Each participant's visit will last approximately two to three hours in total. What are the possible benefits? There may be no direct benefit to participants. However, this study may help researchers understand how small vessel disease affects brain function related to walking, which may improve care for future patients.

NCT Number	NCT07372937
Lead Sponsor	Ain Shams University
Conditions	Cerebral Small Vessel Disease
Enrollment	40 participants
Start Date	2026-03-01
Primary Completion	2026-11-01 (estimated)
Study Completion	2027-03-01 (estimated)
Updated on ClinicalTrials.gov	2026-02-03